AI assistant
Sending…
Cellectar Biosciences, Inc. — Director's Dealing 2018
Dec 1, 2018
35021_dirs_2018-11-30_ef1a7600-bc4a-4b5b-8332-3bbeeddc0cd7.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: Cellectar Biosciences, Inc. (CLRB)
CIK: 0001279704
Period of Report: 2018-11-30
Reporting Person: CARUSO JAMES V (Director, President and CEO)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2018-11-30 | Common Stock, par value $0.00001 per share | P | 1000 | $2.282 | Acquired | 22354 | Direct |
More from Cellectar Biosciences, Inc.
Declaration of Voting Results & Voting Rights Announcements
2026
Jul 10
Regulatory Filings
2026
Jun 2
Regulatory Filings
2026
May 29
Proxy Solicitation & Information Statement
2026
May 28
Proxy Solicitation & Information Statement
2026
May 28
Regulatory Filings
2026
May 19
Board/Management Information
2026
May 18
Earnings Release
2026
May 14
Interim / Quarterly Report
2026
May 14
Capital/Financing Update
2026
May 8